At a Glance: While ECT remains a traditional treatment for severe depression, it often carries risks of cognitive side effects. Ketamine therapy provides a modern, rapid-acting alternative that increases neuroplasticity without inducing seizures, helping you regain your mental health safely and effectively.
When standard antidepressants stop working — or never worked to begin with — two of the most powerful options available for treatment-resistant depression (TRD) are ketamine therapy and electroconvulsive therapy (ECT). Both have compelling evidence. Both can produce meaningful results in patients who have failed multiple prior treatments. And both carry significant misconceptions that can make the decision harder than it needs to be.
This article offers an honest, clinical comparison of the two treatments — what they are, how they work, what the experience is actually like, and when each one makes more sense.
Electroconvulsive therapy is a psychiatric procedure in which brief electrical stimulation is applied to the brain while the patient is under general anesthesia, producing a controlled seizure. It is performed in a hospital or outpatient surgical setting, typically two to three times per week for three to four weeks (six to twelve sessions total).
ECT has been used since the 1930s and has one of the most robust evidence bases in psychiatry — far larger than ketamine’s. It is highly effective for severe, treatment-resistant depression, with response rates often cited between 60 and 80 percent for appropriately selected patients.
The modern version of ECT bears no resemblance to its historical depiction. Patients are fully anesthetized with muscle relaxants, there is no visible convulsion, and the procedure itself lasts only minutes. Patients typically wake up in a recovery room feeling drowsy and disoriented, and most can go home the same day.
Ketamine therapy involves the physician-supervised administration of sub-anesthetic doses of ketamine — most commonly via IV infusion — to rapidly modulate the glutamate system and promote neuroplasticity. A standard initial series involves six infusions over two to three weeks, each lasting approximately 40–60 minutes, without general anesthesia.
Both treatments are among the fastest-acting interventions for severe depression — significantly faster than standard antidepressants.
Ketamine often produces noticeable improvement within hours to days of the first infusion. ECT typically requires two to four sessions — about one to two weeks — before significant improvement appears.
For acute crisis presentations, suicidal ideation, or patients who are severely impaired and need rapid stabilization, ketamine’s speed advantage is clinically meaningful.
ECT has a slight edge on overall response rates in true TRD — particularly for the most severe presentations, including psychotic depression, severe melancholia, and depression with active refusal to eat or drink (catatonic presentations). ECT’s evidence base is simply larger and more established for these extremes.
For moderate-to-severe TRD without psychosis, ketamine and ECT show comparable response rates in the research literature — and ketamine continues to accumulate evidence rapidly.
This is the dimension where the two treatments diverge most significantly.
ECT — particularly bilateral electrode placement — commonly produces memory impairment. Most commonly this involves the period around treatment (anterograde and retrograde amnesia around the ECT sessions), and for most patients this resolves over weeks to months. However, a subset of patients report more persistent memory difficulties, and this remains the most significant concern associated with ECT.
Ketamine does not produce lasting cognitive side effects at therapeutic doses. There is no equivalent memory concern. The acute dissociative experience resolves within hours, and patients consistently show preserved — often improved — cognitive function following a treatment series.
ECT: General anesthesia is required. The patient is unconscious during the procedure. There is no therapeutic “experience.” Side effects in the recovery period include headache, muscle aches, disorientation, and nausea — similar to waking from any general anesthetic.
Ketamine: No general anesthesia. The patient remains conscious throughout in a supported, monitored setting. The experience is immersive and dissociative — many patients describe it as profoundly meaningful, visually rich, emotionally significant, or deeply calming. This experience is not incidental — for many patients, it is a central mechanism of the healing.
ECT requires a hospital or accredited surgical setting, a formal psychiatry referral in most cases, a dedicated anesthesia team, and a family member or caregiver available for each session.
Ketamine can be administered in an outpatient clinic setting like Seaside Ketamine. No hospital affiliation is required. Patients need a driver home but can otherwise manage logistics more independently.
ECT is covered by most insurance plans when medically indicated and ordered by a psychiatrist. However, it is only available at hospital-based facilities — which limits geographic accessibility.
Ketamine therapy is generally not covered by insurance for IV infusions (Spravato/esketamine has separate insurance pathways), but is available at specialized outpatient clinics throughout the San Diego area.
Yes. Ketamine and ECT are not mutually exclusive. Some patients use ketamine to maintain remission achieved by ECT. Others try ketamine first and escalate to ECT if needed. And some patients who cannot tolerate ECT or for whom it’s inaccessible find that ketamine provides an effective alternative pathway.
At Seaside Ketamine, we hold the full landscape honestly. If we believe ECT is the more appropriate option for your specific presentation, we’ll tell you — and help you access the right referral.
ECT requires general anesthesia and induces a controlled seizure, which can lead to temporary memory loss or cognitive impairment. Ketamine therapy avoids seizure induction entirely and does not carry the same risk profile for long-term memory side effects, offering a more gentle clinical experience.
Both treatments are highly effective for treatment-resistant depression. However, many patients prefer ketamine because it provides a much faster onset of relief and an significantly easier recovery process, allowing you to return to your daily life immediately after each session.
Yes. Many of our patients choose to transition to ketamine therapy after experiencing unsatisfactory results or intolerable side effects from ECT. During your initial consultation, we actively evaluate your previous treatment response to create a smooth, safe transition plan tailored specifically to your needs.
Best Place for Ketamine vs ECT for Treatment-Resistant Depression
